DOI: http://dx.doi.org/10.18203/2349-3933.ijam20212410

A prospective study of peripheral arterial diseases in chronic kidney disease patient attending tertiary care hospital Andhra Pradesh

Ramswarup K. Jawaharlal, Vamsi Krishna Mootha

Abstract


Background: Around 10% populations worldwide develop chronic kidney disease and two million people require frequent dialysis due to it1. Cardiovascular diseases related complications are more common in chronic kidney patients and responsible for greater morbidity and mortality. This study is designed to determine the peripheral artery disease in patients with chronic kidney disease in our clinical setup and risk factor associated with them.

Methods: In present study 140 patients with chronic kidney disease were enrolled for this study. Demographic profile of each patient was recorded. Detailed history of patients regarding claudication was taken. Ankle-brachial index was calculated in each patient with CKD for diagnosis of PAD based on American heart association guideline.

Results: There was male predominance. History of smocking was present in 80 (57.14%) patients and absent in 60 (42.85%) patients. Symptom of PAD was present in 28 (20%) patients and absent in 114(80%) patients. Ankle-Brachial Index was positive in 38(27.14%) patients and absent in 102 (72.85%) patients. 80 (57.14%) patients were in stage 3 and 24 (17.14%) patients were in stage 4. Diabetes mellitus was present in 26 (18.57%) patients, Hypertension was present in 64 (45.71%), IHD was present in 22 (15.71%) remaining have no risk factor.

Conclusions: From present study we can conclude that PAD was common in CKD patients more than 50 years of age and here is male predominance. It is more common in smoker and in most of the patients it was asymptomatic. Prevalence of PAD was 27.14% in CKD patients. In our study PAD was more common in stage 3 CKD and least common in stage 2, and cardiovascular risk factor was more common in PAD patients then CKD in general.


Keywords


Peripheral arterial diseases, Chronic kidney disease, Risk factor

Full Text:

PDF

References


Kirsten LJ, Pranav SG, Caitlin WH, Philip AK, Dearbhla MK, Sven M, et al. Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global outcomes (KDIGO) Controversies Conference. Kidney Int. 2021;5:85-9.

Garimella PS, Hirsch AT. Peripheral artery disease and chronic kidney disease: clinical synergy to improve outcomes. Adv Chronic Kidney Dis. 2014; 21(6):460-71.

Sarnak MJ, Levey AS, Schoolwerth AC. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension. 2003;42(5):1050-65.

O'Hare AM. Management of peripheral arterial disease in chronic kidney disease. Cardiol Clin. 2005;23(3):225-36.

DeLoach SS, Mohler ER. Peripheral arterial disease: a guide for nephrologists. Clin J Am Soc Nephrol. 2007;2(4):839-46.

Yevzlin AS, Gimelli G. Diagnosis and treatment of peripheral arterial disease in CKD patients. Semin Dial. 2013;26(2):240-51.

Ix JH, Criqui MH. Epidemiology and diagnosis of peripheral arterial disease in patients with chronic kidney disease. Adv Chronic Kidney Dis. 2008; 15(4):378-83.

Guerrero A, Montes R, Muñoz-Terol J, Gil-Peralta A, Toro J, Naranjo M, et al. Peripheral arterial disease in patients with stages IV and V chronic renal failure. Nephrol Dial Transplant. 2006;21(12): 3525-31.

Ašćerić RR, Dimković NB, Trajković GŽ, Ristić BS, Janković AN, Durić PS,et al. Prevalence, clinical characteristics, and predictors of peripheral arterial disease in hemodialysis patients: a cross-sectional study. BMC Nephrol. 2019;20(1):281.

Sample size calculation using on line calculator. Available at: https://epitools.ausvet.com.au/sample size. Accessed on 25 March 2021.

Levey AS, Stevens LA. Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis. 2010;55(4):622-7.

AHA releases recommendations on ankle-brachial index measurement and interpretation, Available at: http://circ.ahajournals.org/content/126/24/2890.full. Accessed on 25 March 2021.

James PA, Ortiz E. 2014 evidence-based guideline for the management of high blood pressure in adults. JAMA. 2014;311(5):507-20.

American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabete 2019. Diabetes Care 2019;42(1):S13-28

LaMendola B, Altrichter J, Cutillo A, Price A. Peripheral arterial disease and the CKD patient: the case for early screening, diagnosis, and minimally invasive revascularization. Dial Transplant. 2010;39(11):490‐4.

Anantha-Narayanan M, Sheikh A, Nagpal S, Smolderen KG, Turner J, Schneider M, et al. Impact of Kidney Disease on Peripheral Arterial Interventions: A Systematic Review and Meta-Analysis. Am J Nephrol. 2020;51:527-33.

Fowkes FGR, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382 (9901):1329-40.

Laghari S, Ullah K, Masroor I, Butt G, Kifayat F. Prevalence of peripheral arterial disease diagnosed by ankle brachial index among chronic kidney disease patients in a tertiary care unit. Saudi J Kidney Dis Transpl. 2015;26:924-30.

DeLoach SS, Mohler ER. Peripheral arterial disease: A guide for nephrologists. Clin J Am Soc Nephrol. 2007;2:839-46.

Chen J, Mohler ER, Xie D. Risk factors for peripheral arterial disease among patients with chronic kidney disease. Am J Cardiol. 2012;110(1): 136-41.

Wattanakit K, Folsom AR, Selvin E, Coresh J, Hirsch AT, Weatherley BD. Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis risk in communities (ARIC) study. J Am Soci Nephrol. 2007;18(2):629-36.

Liew YP, Bartholomew JR, Demirjian S, Michaels J, Schreiber MJ. Combined effect of chronic kidney disease and peripheral arterial disease on all-cause mortality in a high-risk population. Clin J Am Soc Nephrol. 2008;3(4):1084-9.

O'Hare AM. High prevalence of peripheral arterial disease in persons with renal insufficiency: Results from the National Health and Nutrition Examination Survey. Circulation. 2004;109:320-3.

Cheung AK, Sarnak MJ, Yan G. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int. 2000;58(1):353-62.

Rajagopalan S, Dellegrottaglie S, Furniss AL. Peripheral arterial disease in patients with end-stage renal disease: observations from the dialysis outcomes and practice patterns study (DOPPS) Circulation. 2006;114(18):1914-22.

Salvador T-I, Rafael M-I, Rebeca F-S, Alba R-G, Eduardo H-R, Juan B. Peripheral artery disease and chronic kidney disease: clinical synergy to improve outcomes. Adv Chronic Kidney Dis. 2014;21(6): 460-71.